Table 12.
Prevalence of MetS and its criteria in the female part of the study population [n (%)].
| Parameter | Psychiatric hospital patients, n | |||
|---|---|---|---|---|
| (1) Kemerovo, 46 | (2) Tomsk, 62 | (3) Omsk, 41 | p-value | |
| MetS prevalence | 10 (21.7%) | 22 (35.5%) | 12 (29.3%) | 0.301 |
| Waist circumference | 23 (50.0%) | 43 (69.4%) | 26 (63.4%) | 0.119 |
| Blood pressure | 6 (13.0%) | 15 (24.2%) | 15 (36.6%) | p1−2 = 0.148 |
| p1−3 = 0.01* | ||||
| p2−3 = 0.175 | ||||
| Fasting glucose | 11 (23.9%) | 9 (14.5%) | 4 (9.8%) | 0.181 |
| Triglyceride | 15 (32.6%) | 17 (27.4%) | 6 (14.6%) | 0.143 |
| HDL-C | 38 (82.6%) | 36 (58.1%) | 25 (61.0%) | p1−2 = 0.07 |
| p1−3 = 0.024* | ||||
| p2−3 = 0.769 | ||||
*
p < 0.05, statistically significant difference; these data were analyzed using the χ2 test. MetS, metabolic syndrome; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol.